13F Holdings
中文EN

EMED Electromedical Technologies, Inc

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1715819 · Fiscal year ends 12/31

Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-35.1%
TTM net income YoY46.3%
TTM EPS YoY—
Revenue 3-yr CAGR2.7%
Net income 3-yr CAGR—

Margins

Gross margin75.1%
Operating margin-109.6%
Net margin-182.0%
FCF margin—
EBITDA margin-109.6%

Returns

ROE—
ROA-236.0%
ROIC (approx.)—
Asset turnover1.30x

Leverage & solvency

Liabilities / assets804.1%
Debt / equity—
Current ratio0.07x
Interest coverage-4.38x

Cash quality & payout

Operating cash flow / net income0.08x
Accruals ratio-217.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20232023-12-31FY20222022-12-31FY20212021-12-31FY20202020-12-31FY20192019-12-31
Income statement
Revenue$1.35M$1.15M$907,362$737,958$829,737
Cost of revenue$303,303$261,203$199,234$194,384$238,516
Gross profit$1.05M$888,641$708,128$543,574$591,221
R&D expense$231,434$92,299$215,320$31,600$82,849
SG&A expense$3.11M$2.49M$4.51M$3.71M$2.26M
Operating income-$2.06M-$1.60M-$3.80M-$3.17M-$1.67M
Interest expense$893,155$791,072$3.31M$769,591$54,814
Net income-$2.64M-$3.47M-$8.48M-$3.87M-$1.74M
EBITDA-$2.06M-$1.58M-$3.78M-$3.14M-$1.64M
EPS (basic)0.00-0.03-0.24-0.20-0.10
EPS (diluted)0.00-0.03-0.24-0.20-0.10
Weighted avg. shares (diluted)377.22M133.60M50.99M22.30M16.81M
Balance sheet
Cash & equivalents$87,704$368,425$383,170$264,913$0
Receivables$4,399$9,444$35,085$17,694$15,667
Inventory$68,517$62,061$218,510$78,712$24,694
Current assets$449,185$647,802$674,767$647,179$106,192
PP&E, net$149,705$705,469$727,344$749,219$771,094
Total assets$748,383$1.35M$1.40M$1.42M$902,866
Current liabilities$3.36M$2.92M$1.44M$2.02M$2.30M
Long-term debt$150,000$671,525$702,780$732,266—
Total debt$150,000$671,525$702,780$732,266—
Total liabilities$3.62M$3.57M$2.12M$2.74M$3.09M
Shareholders' equity-$2.87M-$2.22M-$722,503-$1.32M-$2.18M
Net debt$62,296$303,100$319,610$467,353—
Shares outstanding463.29M189.78M87.73M27.18M17.90M
Cash flow statement
Operating cash flow-$1.42M-$773,337-$1.19M-$1.34M-$280,772
Capital expenditure$149,705————
Free cash flow-$1.57M————
Investing cash flow$1.74M————
Financing cash flow-$608,211$758,592$1.31M$1.60M$280,772
Depreciation & amortization$4,557$21,875$21,875$21,875$24,457
Stock-based compensation$715,000$509,603$2.63M$2.22M$801,287

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.